Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochem Med (Zagreb) ; 25(2): 252-61, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26110038

RESUMEN

INTRODUCTION: Sparse data are available about the effect of therapy methods on antibody levels in patients with liver failure. The aim of this study was to determine serum immunoglobulin concentrations in patients with chronic hepatic failure (CHF), acute- (ALF), or acute-on-chronic liver failure (ACLF) and to evaluate the impact of MARS treatment or liver transplantation (LT) on antibody levels. MATERIALS AND METHODS: We followed ten patients with ALF, twelve with ACLF and 18 with CHF. Eight patients with ALF and seven with ACLF underwent MARS therapy, whereas the rest received LT. 13 healthy volunteers served as controls. Serum antibody concentrations were measured using ELISA-technique. RESULTS: Median serum levels of IgA, IgG and IgM were significantly increased in patients with CHF compared to ALF or controls (P<0.02, P<0.01, and P<0.01). IgM and IgG concentrations were also significantly elevated in patients with CHF compared to ACLF (IgM, 3.7 vs. 1 g/L, P<0.001; IgG, 8.7 vs. 3.1 g/L, P=0.004). Immediately after LT a significant decrease of IgA (6.9 vs. 3.1 g/L, P=0.004), IgG (8.7 vs. 5.1 g/L, P=0.02) and IgM (3.7 vs. 1.8 g/L, P=0.001) was detected in patients with CHF and antibody levels further decreased the days after LT reaching levels comparable to healthy individuals. MARS treatment had no apparent effect on the immunoglobulin profile in patients with ALF or ACLF. CONCLUSION: We provide evidence that LT reverses hypergammaglobulinemia in patients suffering from CHF within one day, which could be explained to a reconstituted hepatic antibody clearance, whereas MARS treatment has no immediate effect on immunoglobulin levels.


Asunto(s)
Enfermedad Hepática en Estado Terminal , Hipergammaglobulinemia , Trasplante de Hígado , Adolescente , Adulto , Anciano , Enfermedad Hepática en Estado Terminal/sangre , Enfermedad Hepática en Estado Terminal/complicaciones , Enfermedad Hepática en Estado Terminal/cirugía , Femenino , Estudios de Seguimiento , Humanos , Hipergammaglobulinemia/sangre , Hipergammaglobulinemia/complicaciones , Hipergammaglobulinemia/cirugía , Inmunoglobulinas , Fallo Hepático Agudo/sangre , Fallo Hepático Agudo/complicaciones , Fallo Hepático Agudo/cirugía , Masculino , Persona de Mediana Edad
4.
Arch Ophthalmol ; 119(2): 293-6, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11176997

RESUMEN

We report the clinical findings and analysis of the immunoglobulin (Ig) composition of the vitreous of a 10-year-old girl with juvenile rheumatoid arthritis-associated uveitis. The vitreous had a schlieren appearance at the time of pars plana lensectomy and vitrectomy. Analysis of the vitreous fluid revealed marked elevation of IgG, IgM, IgA, and albumin levels relative to vitreous fluids from control patients without uveitis. The immunoglobulin coefficients were also elevated for the IgG and IgM classes of immunoglobulins. Immunofixation electrophoresis of the vitreous fluid revealed 2 distinct bands of restricted electrophoretic mobility. These studies suggest that there may be local (intraocular) production of immunoglobulins as an immunologic response in ocular inflammatory diseases such as juvenile rheumatoid arthritis-associated uveitis and that this immunologic response may be monoclonal (possibly biclonal or oligoclonal) in nature.


Asunto(s)
Artritis Reumatoide/complicaciones , Hipergammaglobulinemia/complicaciones , Inmunoglobulinas/metabolismo , Errores de Refracción/etiología , Uveítis/etiología , Cuerpo Vítreo/inmunología , Anciano , Anciano de 80 o más Años , Albúminas/metabolismo , Artritis Reumatoide/inmunología , Niño , Femenino , Humanos , Hipergammaglobulinemia/inmunología , Hipergammaglobulinemia/cirugía , Cristalino/cirugía , Persona de Mediana Edad , Procedimientos Quirúrgicos Refractivos , Uveítis/inmunología , Vitrectomía
6.
HNO ; 47(7): 637-41, 1999 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-10463116

RESUMEN

Sjögren's syndrome is an important autoimmune disease in the head and neck. Patients have an increased arrival risk of up to 6% per year for developing B-cell lymphomas, including mucosa-associated lymphoid tissue (MALT) lymphomas. The following case report shows this relation and the difficulty of differentiating clinically recurrent swelling of the parotid gland in Sjögren's syndrome from malignant lymphoma. A 64-year-old woman had a 2-year history of indolent, recurrent swelling of both parotid glands. Blood examination showed elevated ESR and a hypergammaglobulinemia. Immunosuppressive therapy produced no improvement. Two years after the diagnosis of Sjögren's syndrome, swelling of the left parotid gland persisted. Superficial parotidectomy of the left side was performed and histopathological examination revealed a MALT-related lymphoma. Subsequent parotidectomy of the right side also showed infiltration of the gland by a MALT lymphoma. Postoperative radiation therapy was given. During the follow-up period no recurrence or systemic disease was detected. Patients with Sjögren's syndrome should be examined regularly by the otolaryngologist. If a lymphoma cannot be ruled out, open biopsy must be considered for histological diagnosis. Prognostic factors for developing a lymphoma are possibly a high ESR and hypergammaglobulinemia. Further prognostic factors have to be evaluated.


Asunto(s)
Linfoma de Células B de la Zona Marginal/diagnóstico , Neoplasias de la Parótida/cirugía , Síndrome de Sjögren/diagnóstico , Sedimentación Sanguínea , Diagnóstico Diferencial , Femenino , Humanos , Hipergammaglobulinemia/diagnóstico , Hipergammaglobulinemia/patología , Hipergammaglobulinemia/cirugía , Linfoma de Células B de la Zona Marginal/patología , Linfoma de Células B de la Zona Marginal/cirugía , Persona de Mediana Edad , Glándula Parótida/patología , Glándula Parótida/cirugía , Neoplasias de la Parótida/patología , Factores de Riesgo , Síndrome de Sjögren/patología , Síndrome de Sjögren/cirugía
8.
Klin Monbl Augenheilkd ; 197(5): 432-5, 1990 Nov.
Artículo en Alemán | MEDLINE | ID: mdl-2290301

RESUMEN

The Hyperimmunoglobulinemia-E-Syndrome (HIE) is characterized by high levels of serum-IgE, diminished counts of T-suppressor-cells, eosinophilia, and disturbed chemotactic functions of neutrophil granulocytes. An 8 years old female, suffering from hyperimmunoglobulinemia E (HIE), showed marginal corneal ulcera since five years. Positive conjunctival smears included several bacterias and chlamydia, but never local herpes virus. Inspite of treatment by antibiotics, virostatica, and therapeutical contact lens, a spontaneous corneal perforation occurred. A penetrating keratoplasty was successful for a short time, but soon ulceration rose again. At last a second penetrating keratoplasty was necessary. The early status showed tidy results, but some weeks later marginal ulceration occurred again. There was no clinical proof for herpetical genesis of the course, but evidence is conceivable for pathomechanisms similar to conjunctivitis vernalis.


Asunto(s)
Úlcera de la Córnea/diagnóstico , Hipergammaglobulinemia/diagnóstico , Inmunoglobulina E/análisis , Niño , Trasplante de Córnea/inmunología , Úlcera de la Córnea/inmunología , Úlcera de la Córnea/cirugía , Diagnóstico Diferencial , Femenino , Estudios de Seguimiento , Humanos , Hipergammaglobulinemia/inmunología , Hipergammaglobulinemia/cirugía , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/inmunología , Recurrencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...